Biotechnology Neurology-Focused Axsome Therapeutics Reports Deeper Than Expected Q4 Loss, Updates Upcoming Pipeline Milestones – Axsome Therapeutics (NASDAQ:AXSM) Read more
Biotechnology Chikungunya Vaccine Maker Valneva Secures Non Dilutive Funding To Develop/Expand Its Clinical Pipeline – Valneva (NASDAQ:VALN) Read more